Showing results (31-40 of 269) with videos related to
Sort By:
Pageof 27
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
Depletion of protein kinase C-alpha by antisense oligonucleotides alters beta-adrenergic function and reverses the phorbol ester-induced reduction of isoproterenol-induced adenosine 3'-5'-cyclic monophosphate accumulation in murine Swiss 3T3 fibroblastsL Levesque, S T CrookeScandinavian Journal of Rheumatology. Supplement|January 1, 1986
The cellular and molecular pharmacology of auranofin and related gold complexesS T Crooke, R M SnyderBiochemistry|January 14, 1997
Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybridsW F Lima, S T CrookeAnnual Review of Pharmacology and Toxicology|January 1, 1996
Progress in antisense oligonucleotide therapeuticsS T Crooke, C F BennettCell Calcium|July 1, 1989
Mammalian phosphoinositide-specific phospholipase C isoenzymesS T Crooke, C F BennettProceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Highly efficient endonucleolytic cleavage of RNA by a Cys(2)His(2) zinc-finger peptideW F Lima, S T CrookeCancer Research|August 1, 1985
Effects of structural modifications of antitumor antibiotics (luzopeptins) on the interactions with deoxyribonucleic acidC H Huang, S T CrookeDiseases of the Colon and Rectum|October 5, 2001
The concept and application of antisense oligonucleotidesB R Yacyshyn, S T CrookeThe American Journal of Medicine|December 30, 1983
Molecular mechanisms of action of auranofin and other gold complexes as related to their biologic activitiesS T Crooke, C K MirabelliAnti-Cancer Drug Design|April 1, 1986
Effects of structural modifications of anti-tumour antibiotics luzopeptins on cell growth and macromolecule biosynthesisC H Huang, S T CrookePageof 27